An Israeli AI Copilot for Florida's Doctors
Navina's AI physician copilot, backed by a $55M Goldman-led Series C, is expanding into Florida's value-based-care market.
FLORIDA — The Israeli technology reshaping Florida is not confined to server rooms and seawalls. Some of it is walking into the exam room. As the state's doctors face an aging population, a mounting documentation burden, and a healthcare system racing to reward outcomes over volume, an Israeli-founded company is offering them something that sounds almost too simple: an artificial-intelligence copilot that reads the entire patient chart so the physician doesn't have to.
Navina, whose AI platform synthesizes a lifetime of scattered medical data into a single, physician-ready view, is expanding across the U.S. healthcare market — and Florida, with one of the largest and most complex patient populations in the country, is a natural front line. The company is betting that the future of primary care is not more screens and more clicks, but an intelligent layer that hands the doctor the answer before they have to go hunting for it.
The AI That Reads the Whole Chart
Every practicing physician knows the problem Navina is built to solve. A single patient's history is scattered across claims files, lab results, imaging reports, specialist notes, prescription records, and years of accumulated documentation — often in different systems that do not speak to one another. In a fifteen-minute visit, no human can reliably absorb all of it. Critical details get missed. Diagnoses go unrecorded. Care gaps slip through.
Navina's platform acts as a clinical copilot. It ingests that fragmented data and distills it into a clear, organized summary at the point of care — surfacing likely diagnoses, flagging gaps in documentation and quality measures, and giving the physician a coherent picture of the patient in seconds rather than minutes. The pitch is not to replace the doctor's judgment. It is to remove the administrative fog that stands between the doctor and their judgment, letting them spend the visit on the patient instead of on the chart.
Investors have taken the thesis seriously. In 2025, Navina raised a $55 million Series C led by Goldman Sachs, capital directed squarely at scaling the platform with large medical groups and value-based care organizations. That round followed earlier raises that built the product and proved it inside real clinical settings. The trajectory is the one every enterprise health-tech company wants: from promising tool to embedded infrastructure.
Why Florida Is the Front Line
If Navina were choosing the single most valuable market in America to prove its worth, it would be hard to design a better one than Florida. The state has one of the nation's largest populations of residents over 65, which makes it one of the deepest Medicare and Medicare Advantage markets in the country. Older patients carry more conditions, more medications, and more accumulated records — precisely the complexity Navina's AI is built to untangle.
Florida is also a national hub for value-based care, the payment model that rewards providers for keeping patients healthy rather than for the volume of services they bill. Some of the country's most prominent value-based primary care organizations built their businesses on Florida's senior population. In that model, accurate documentation and early identification of conditions are not paperwork — they are the economic engine of the practice. A tool that helps physicians capture the full clinical picture translates directly into better care and better performance under value-based contracts.
Add a persistent strain on physician time and a nationwide shortage of primary care doctors, and the value proposition sharpens further. Every minute Navina saves a Florida physician buried in charts is a minute returned to a patient — or to a schedule stretched thinner every year. The technology is not looking for a use case in Florida. Florida is the use case.
Israel's Healthtech Engine
Navina is one expression of a broader national strength. Israel has become one of the world's most productive sources of digital-health and medical-AI innovation, powered by a rare combination: elite engineering and data-science talent, a long tradition of military-grade AI and signal processing, and a national health system whose digitized records created fertile ground for clinical-AI development. Israeli founders have repeatedly taken that foundation and built companies aimed at the far larger American healthcare market.
That is the arc Navina is now completing — Israeli-built clinical intelligence, deployed where the American system needs it most, and increasingly, where the American system is most concentrated: Florida.
The Corridor Around It
Navina's U.S. push rides a documented structural shift. 429 Israeli-founded companies now operate in Florida, generating $7.3 billion in economic output and supporting 26,510 jobs, according to a 5W study built on the United States–Israel Business Alliance's Florida–Israel Economic Impact Report. Health and life-sciences firms form one of the corridor's densest clusters — drawn by the market, the talent, and a state actively courting Israeli innovation. Those firms pay a 12% wage premium over the state average, concentrating exactly the high-skill jobs that states compete to attract.
For a healthtech company, proximity to the market is not a convenience — it is a competitive advantage. Being close to the health systems, the medical groups, and the patient population you serve shortens every feedback loop between product and practice. Florida offers Navina all three in unusual density.
The Infrastructure Underneath
The corridor Navina is entering is held together by real infrastructure. Direct daily flights between Tel Aviv and South Florida keep Israeli teams close to their American operations. The Florida-Israel Business Accelerator has helped more than 100 Israeli companies establish U.S. headquarters. Israel Tech Week — up to 2,200 attendees this year from 1,500 — has become the connective tissue linking founders to capital and customers. And Florida's role as a gateway to Latin America opens a second horizon for any company that establishes itself in the state, from a single time zone.
What Comes Next
The direction of American healthcare is set: more value-based care, more aging patients, more data, and more pressure on the physicians in the middle of it all. Every one of those trends deepens the need for exactly what Navina builds. And every one of them is more concentrated in Florida than almost anywhere else in the country.
That alignment — an Israeli company built for the precise problem a state is racing to solve — is what turns an arrival into a fixture. Navina came to Florida because that is where the patients, the physicians, and the payment models that reward its technology all converge. The Israeli tech story in Florida began with the industries you would expect. It is now sitting quietly in the exam room, reading the chart, and handing the doctor back their time.
About Navina
Navina is an Israeli-founded health-technology company whose AI platform acts as a "copilot" for physicians — synthesizing fragmented patient data into a clear, actionable view at the point of care to support primary care and value-based care. In 2025 the company raised a $55 million Series C led by Goldman Sachs.
Disclosure: This article references research produced by 5W. Olam and 5W AI Communications share common ownership. Olam reports independently on the Florida–Israel corridor, including on research produced by 5W. Editorial decisions are made by Olam's editorial team.
